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Background: Fibroblasts play a critical role in tumorigenesis, tumor progression and metastasis. However, their
detailed molecular characteristics and clinical significance are still elusive. TAGLN is an actin-binding protein that
plays an important role in tumorigenesis.
Results: We investigated the interaction between cancer cells and the tumor microenvironment to determine how
the fibroblasts from human gastric carcinoma facilitate tumorigenesis through TAGLN. QRT-PCR and Western blot
indicated that TAGLN expression was upregulated in gastric carcinoma-associated fibroblasts (CAFs) that promote
gastric cancer cell migration and invasion. Using small interfering RNA (siRNA), we found that CAFs enhanced
tumor metastasis through upregulated TAGLN in vitro and in vivo. The expression of matrix metalloproteinase-2
(MMP-2) was significantly lower after TAGLN knock-down by siRNA. TAGLN levels were elevated in human gastric
cancer stroma than normal gastric stroma and associated with differentiation and lymph node metastasis of
gastric cancer.
Conclusion: CAFs may promote gastric cancer cell migration and invasion via upregulating TAGLN and TAGLN
induced MMP-2 production.
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Gastric carcinoma is the second most common causes of
cancer-related deaths in the world, especially in Asia [1,2].
Most of gastric cancer patients died of tumor recurrence
caused by distant metastasis. Metastasis is a multi-stage
process by which cancer cells disseminate from the
primary neoplasm and invade surrounding tissue and
distance organs, involving cancer cell motility,
intravasation, transit in the blood or lymph and extravasa-
tion [3]. This process depends tightly on the surrounding
microenvironment and tumor development relies on a
continuous cross-talk between cancer cells and extracellular
microenvironments [4].* Correspondence: byliu@sjtu.edu.cn
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reproduction in any medium, provided the orTransgelin (TAGLN, also known as SM22) is an actin
cross-linking protein that is involved in calcium interactions
and regulates contractile properties [5]. It may play a role
in cell differentiation, cell migration cell invasion and
matrix remodeling by stabilizing the cytoskeleton through
actin binding [6,7]. Overexpression of TAGLN protein has
been observed in carcinomas of the stomach, liver, and
esophagus, while decreased levels of TAGLN mRNA have
been observed in breast and colon cancer cell lines and
primary tumors [8].
It is generally accepted that tumor-stroma interactions
play an important role in tumor development and progres-
sion. The stroma is constituted mainly of extracellular
matrix (ECM) and cellular elements, such as fibroblasts
[9,10]. The cellular components of the stroma are
well-recognized as having a supportive role in carcinoge-
nesis [11,12]. These stromal elements act in a synergistic
cross-talk with cancer cells from the primary sites toThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The expression of TAGLN is upregulated in gastric cancer-associated fibroblasts. A: characterization of gastric fibroblasts (ICC). a1:
vimentin, positive. a2: α-SMA, positive. a3: fibronectin, positive. a4: cytokeratin, negative. Original magnifications: ×200. Scale bars, 100 μm. B: QRT-
PCR analysis of TAGLN in CAF, CPF and NF. *, P < 0.05, **, P < 0.01, compared to NF. C: Western blot analysis of TAGLN in CAF, CPF and NF, TAGLN
expression level was decreased successively. D: fibroblasts growth curve were determined by CCK-8 assay, CAFs grew quickier than the others.
E: CAF had higher ability to enhance MKN-45’s migration ability than CPF and NF, ***, P < 0.001 compared to MKN-45. F: CAF had higher ability to
enhance MKN-45’s invasion ability than CPF and NF, *, P < 0.05, **, P < 0.01, compared to MKN-45.
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tumor stroma which is referred to as a “reactive stroma”
is associated with an increased number of fibroblasts, en-
hanced capillary density and deposition of a new ECM rich
in type-1-collagen and fibrin [15]. Accumulating evidencereveals that stromal cells, such as fibroblasts have a more
profound influence on the development and progression of
carcinoma than was previously appreciated [15-17].
Fibroblasts are well-known to play roles in tumorigenesis
and progression. Fibroblasts express vimentin, fibronectin,
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protein as well as fibroblastic markers. Carcinoma-
associated fibroblasts (CAFs) are activated fibroblasts,
biologically different from fibroblasts present in benign
microenvironments in several important aspects [17,18].
CAFs are not passive bystanders in tumorigenesis and
metastasis, but contribute actively to these processes [19].
Our knowledge on the role of resting and activated fibro-
blasts in cancer is still evolving. Here, we focus on the
interaction between cancer cells and their microenviron-
ments to study how the fibroblasts isolated from human
gastric carcinomas facilitate tumorigenesis.
Results
The expression of TAGLN is upregulated in gastric
carcinoma-associated fibroblasts
The carcinoma-associated fibroblasts (CAFs), counterpart
fibroblasts (CPFs) and normal fibroblasts (NFs) were
obtained from primary tissue culture using tissues from
cancer-associated regions, non-cancer-associated stroma
and normal mucosa, respectively. We then verified the
purity of the various fibroblast populations by immuno-
staining. These fibroblast populations expressed high levls
of fibroblastic markers such as vimentin, α-SMA andFigure 2 CAFs enhance tumor cell line MKN-45 migraton and invasio
analysis after siRNA knockdown in fibroblasts. B: TAGLN expression by Wes
assay in vitro (fibroblasts with or without TAGLN siRNA interference). D: cel
interference). Values represent the mean ± SD from at least three separate
P < 0.001, by one-way analysis of variance (ANOVA).fibronectin. On the other hand, these cells did not express
epithelial markers such as cytokeratin (Figure 1A).
These data confirmed the purity of the fiborblasts.
These observations indicate that the culture cells were
predominantly fibroblasts were prepared with minimal
contamination by other cells.
The mRNA and protein levels of TAGLN were lower
in CPFs and NFs compared with CAFs (Figure 1B and
C). We first showed that CAFs grew significantly more
than CPFs and NFs in vitro cell proliferation (Figure 1D).
Next, we carried out cell invasion and migration assay to
test whether the invasion and migration ability of gastric
cancer cells would be enhanced by fibroblasts. The
experiment was designed to investigate the effects of
stroma TAGLN, which was secreted by fibroblasts, on
human gastric cancer cells. The internal levels of
TAGLN in gastric cancer cells might interfere the
experimental process. Hence, we choosed MKN-45 cell
line, because its TAGLN expression level was the lowest
in seven gastric cancer cell lines (SNU-1, AGS, NCI-N87,
KATOIII, MKN-45, MKN-28 and SGC-7901; data not
shown). Interestingly, the invasion and migration ability of
MKN-45 increased in all the three groups (CAFs, CPFs
and NFs), and increased most in the group with CAFn through upregulated TAGLN. A: TAGLN expression by QRT-PCR
tern blot analysis after siRNA knockdown in fibroblasts. C: cell migration
l invasion assay in vitro (fibroblasts with or without TAGLN siRNA
experiments, each conducted in triplicate. *, P < 0.05, **, P < 0.01, ***,






CAF-MKN45 CPF-MKN45 NF-MKN45 MKN45 alone
Number of tumor-bearing mice 2 5 5 3 2 2
Number of metastatic nodules 2 10 9 5 3 2
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invasive behavior is one of steps in the metastatic
process.
CAFs promote tumor metastasis through upregulating
TAGLN
To examine the effect of TAGLN in fibrobalsts, we used
RNAi to knock down TAGLN expression. CAFs, CPFs and
NFs were transfected with TAGLN-specific or non-silence
siRNA. RNA and protein were obtained at 24, 48 or 72 hrs
after transfection, TAGLN mRNA and protein levels were
investigated by QRT-PCR and Western blot. TAGLN
mRNA and protein were significantly inhibited in cells
treated with TAGLN-specific siRNA (Figure 2A and B).
We next investigated whether the invasion and migration
ability of gastric cancer cells will be enhanced by the
expression of TAGLN in fibroblasts, we carried out cell
invasion and migration assay in vitro. The fibroblasts and
MKN-45 were non-contactedly co-cultured. Interestingly,
the invasion and migration ability of MKN-45 decreased
immediately in the group with CAFs and decreased
slightly in the group with CPFs and NFs. The results
showed that the invasion and migration ability of MKN-
45 can decrease through down-regulating the expression
of TAGLN (Figure 2C and D).
In order to assess the contribution of CAFs-TAGLN to
tumor metastasis in vivo, we emplyed a xenograft model.Figure 3 TAGLN enhances tumor metastasis through human tumor x
a1: lung metastatic nodules from tomur-bearing mouse. Arrow: metastatic
metastatic nodule under bright-field microscope. Scale bars, 200 μm. a4: H
microscope. Scale bars, 200 μm. B: quantification of nude mice lung metas
P < 0.05, by one-way analysis of variance (ANOVA).We mixed TAGLN siRNA CAFs, non-silenced CAFs,
CPFs and NFs with MKN-45 human gastric cancer cells
in a 2:1 ratio or MKN-45 alone and inoculated these cells
through tail intravenous injection in immunodeficient
nude mice. After 6 weeks, MKN-45 mixed with CAFs
generated more lung metastatic nodules than MKN-45
mixed with TAGLN siRNA CAFs, CPFs and NFs, similar
to MKN-45 mixed with non-silence siRNA CAFs (Table 1).
These data suggested that CAFs show an increased ability
to stimulate tumor metastasis (Figure 3A and B). All the
observations indicated that in the presence of CAFs,
tumors became more aggressive, suggesting that CAFs
might play roles in promoting metastasis in gastric cancer.
TAGLN promotes tumor metastasis by upregulating MMP-2
Many studies have focused on the role of matrix
metalloproteinases (MMPs) to the invasion of surrounding
connective tissue and metastasis of tumor cells from the
primary lesion to distant sites in tumor progression
[20,21]. In our previous work, we examined MMP-1,
MMP-2, MMP-3, MMP-7 and MMP-9 levels after TAGLN
knock-down by siRNA through ELISA, only MMP-2 level
was significantly down-regulated, other MMPs levels
showed no change. Hence, we focued on MMP-2 in this
study. As Figure 4A showed, compared to MKN-45
co-coultured with CAF/neg and CAF/mock, MMP-2
levels in supernatant from MKN-45 co-cultured withenograft model in vivo. A: nude mice metastatic nodules in the lung.
nodule. a2: no metastatic nodule in lung. a3: H&E staining for lung
&E staining for lung without metastatic nodule under bright-field
tatic nodules in various groups through tail intravenous injection. *,
Figure 4 TAGLN enhances tumor metastasis by upregulated MMP-2. A: MMP-2 expression in CAF decresed obviously after TAGLN RNAi by
ELISA. *, P < 0.05 by one-way analysis of variance (ANOVA). Error bars depict the standard error around the mean. B: knockdown TAGLN impaired
the ability of CAF to secret MMP-2 by gelatin zymography.
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examined the activity of MMP-2 using gelatin zymography
assay. We found MMP-2 activity was dramatically
inhibited in supernatant from MKN-45 co-cultured with
CAF/siTAGLN than with CAF/neg and CAF/mock
(Figure 4B). Thus, TAGLN may enhance tumor metastasis
through the MMP-2 enzymes degrade the basement
membranes (eg. collagen IV).
TAGLN expression in human gastric cancer and its
association with differentiation in gastric cancer patients
To evaluate the TAGLN expression in gastric cancer,
TAGLN immunostaining in 98 primary gastric cancerFigure 5 Expression of TAGLN in human gastric cancer tissues. A: TAG
B: TAGLN is overexpressed in the stroma of human gastric cancer by IHC. S
cancer analyzed by QRT-PCR. D: TAGLN protein is upregulated in human gast
from at least three separate experiments, each conducted in triplicate. *, P < 0tissues were examined. TAGLN expression was upregulated
in human gastric cancer stroma compared to normal
gastric tissue (Figure 5A: normal gastric tissue; Figure 5B:
gastric cancer tissue). The correlation of TAGLN expres-
sion with the clinicopathological features was shown in
Table 2. TAGLN levels were higher in undifferentiated
tumors (poorly differentiated adenocarcinomas, signet ring
cell carcinomas and mucinous carcinomas) than that in
differentiated ones (well and moderate adnocarcinomas)
(P = 0.003). Moreover, TAGLN levels was correlated with
lymph node metastasis (P = 0.029). There were no signifi-
cant differences in tumor TAGLN expression according to
the other clinicopathological features such as gender,LN expression level in normal gastric tissue by IHC. Scale bars, 100 μm.
cale bars, 100 μm. C: TAGLN mRNA is upregulated in human gastric
ric cancer analyzed by Western blot. Values represent the mean ± SD
.001 by paried-samples T test.
Table 2 Clinicopathological associations of TAGLN






Male 60 27 33
Female 38 16 22
Age 0.739
≤60y 46 21 25
>60y 52 22 30
Tumor size 0.852
≤5 cm 58 25 33
>5 cm 40 18 22
Differentiation 0.003
Well + Moderate 46 13 33
Poor 52 30 22
Lauren classification 0.059
Intestinal 40 13 27
Diffuse 58 30 28
T stage 0.142
T1 + T2 56 21 35
T3 + T4 42 22 20
Lymph node metastasis 0.029
N0 27 11 16
N1 32 15 17
N2 26 7 19
N3 13 10 3
Distant metastasis 0.709
Without 95 42 53
With 3 1 2
TNM stage 0.722
I 20 7 13
II 25 11 14
III 30 10 20
IV 23 15 8
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metastasis and TNM stage (P ≥ 0.05).
Also, we used QRT-PCR and Western blot to evaluate
the expression of TAGLN in gastric cancer tissues
(Figure 5C and D). These results suggested that the
TAGLN expression in gastric cancer tissues was much
higher in gastric cancer than that in paired normal tissues.
Discussion
Accumulating evidence demonstrates that cancer initiation
and progression involve interactions between both tumor
and stromal cells. Tumor cells can actively recruit stromalcells, such as vascular cells, smooth muscle cells and
fibroblasts, into the tumor, thus generating microenviron-
ment to foster tumor growth [16,22,23]. Fibroblasts often
constitute the majority of the stromal cells within a gastric
carcinoma, yet the functional contributions of these
cells to tumorigenesis and tumor metastasis remain
poorly understood.
TAGLN is one of the earliest markers of smooth muscle
differentiation during embryogenesis [24], and previous
studies related to TAGLN mainly focused on smooth
muscle cells [25]. Pathological conditions accompanied
with tissue remodeling and fibrogenesis, such as wound
healing and neoplastic lesions, are characterized by the
appearance of stromal cells with ultrastructural features
intermediate between those of typical fibroblasts and
those of smooth muscle cells. These fibroblasts exhibit
phenotypic and functional features of smooth muscle cells
and hence are named myofibroblasts [26], such as CAFs.
In Our study, TAGLN overexpression was also observed
in CAFs. It is reported that the TAGLN protein is
overexpressed in gastric cancer when protein expression
spectrum of gastric cancer was analyzed using two-
dimensional gel electrophoresis (2-DE) [27]. Furthermore,
the TAGLN protein is one of the two tumor-associated
antigens which were identified in serum of kidney
carcinoma patients by Klade using 2-DE [28]. These
reports are consistent with the findings that we have
observed using real-time PCR and Western Blot. Interest-
ingly, we found that TAGLN was mainly detected in fibro-
blasts derived from tumor stroma, rather than in tumor
cells. Similarly, other investigators discovered that the
TAGLN is not expressed in the malignant cells but in
mesenchymal cells of the tumor stroma [27].
Stromal fibroblasts regulate endothelial or epithelial cell
behavior through direct and indirect cell-cel1 interactions.
Activation of host stroma1 microenvironment is thought
to be a critical step in tumor growth and progression
[13,29]. Proteins secreted by stromal cell in the tumors
may positively or negatively affect tumor progression.
The most prominent actions of TAGLN may favor
tumor cell motility and invasion [7,30,31]. We found
that the TAGLN was significantly increased in lymph
node metastasis group than lymph node negative
group. To c1arify the role of TAGLN in stromal
fibroblasts during gastric cancer tumorigenesis and
metastasis, we silenced the TAGLN expression in
human CAFs. It was indicated that only the MKN-45
co-cultured with CAFs expressing high level TAGLN
exhibited much higher invasion and migration ability.
Fibroblasts which TAGLN had been knocked down
did not display this function. Taken together, we
suggest that TAGLN might be responsible for the
enhancement of gastric cancer cell metastasis via
stromal cells such as CAFs.
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CAFs. CAFs with increased TAGLN expression levels
may enhance tumor cell invasion and migration ability
which promote an enhanced expression of MMP-2. The
stimulation of MMP expression in fibroblasts either after
direct contact with tumor cells or after contact with tumor
cell-derived soluble factors from tumors originating from
epithelial cells has been shown in several studies [32-35].
Clarifying the underlying mechanisms may therefore
attenuate the tumor recurrence and metastasis in gastric
cancer patients.
Conclusions
In summary, our study demonstrates that CAFs may
promote gastric cancer cell migration and invasion via




A total of 40 pairs of cancer tissues and corresponding
normal mucosa for QRT-PCR and Western blot and 98
primary gastric cancers for immunostaining were collected
from surgically removed gastric cancer diagnosed at the
Department of Surgery, Ruijin hospital, Shanghai Jiao
Tong University School of Medicine. Normal mucosa
samples were taken from the margin of the resection
where the tumors located at least over 6 cm apart from it.
This study protocol was approved by the independent
ethics committee of Ruijin Hospital, Shanghai Jiaotong
University, School of Medicine. The informed consent
was written. All samples were snap frozen in liquid
nitrogen overnight and kept at −80°C before use. 4%
Formaldehyde-fixed tissue sections of both tumor and
mucosa were stained with H&E and examined and
verified histopathologically by two pathologists. Each
specimen was attributed a diagnosis and scored for Lauren
classification, differentiation, pTNM stage. Tumor size,
location and other clinical pathological characteristics were
obtained from clinical records with patient permission.
Cell lines
Gastric cancer cell lines SNU-1 (ATCC: CRL-5971), AGS
(ATCC: CRL-1739), NCI-N87 (ATCC: CRL-5822) and
KATOIII (ATCC: HTB-103) were obtained from the
American Type Culture Collection (Manassas, VA, USA).
Another 3 gastric cancer cell lines, MKN-45, MKN-28
and SGC-7901, were preserved at our institute. All cell
lines were maintained in RPMI-1640 supplemented with
10% fetal bovine serum (FBS).
Antibodies
Primary antibodies used for staining included human
specific anti-vimentin (Abcam, Cambridge, UK), anti-fibronectin (Abcam, Cambridge, UK), anti-α-smooth-
muscle actin (Sigma Chemical, St Louis, MO, USA), anti-
pan-cytokeratin (Abcam, Cambridge, UK), anti-SM22
(Abcam, Cambridge, UK), and mouse anti-GAPDH
(Kangchen, China).Isolation of human gastric fibroblasts
Fibroblasts were isolated from cancer- and non-cancer-as-
sociated regions of gastric tissues dissected from patients
with gastric cancer during radical gastric resection from
the Department of Surgery, Ruijin hospital, Shanghai Jiao
Tong University School of Medcine. The cancer-associated
regions were selected to be minimally necrotic regions of
the tumor mass. Non-cancer-associated stroma, which was
isolated from tissue at least 2 cm distal to the outer margin
of the cancer mass. Normal mucosa samples were taken
from the margin of the resection where the tumors located
at least over 6 cm apart from it. Tissues were minced into
organoids of approximately 1 mm3 and seeded on un-
coated plastic material in RPMI 1640 medium containing
human basic fibroblast growth factor, 20% fetal calf
serum (FCS) and penicillin and streptomycin as antibi-
otics. These conditions produced a homogenous fibro-
blastic cell population after 7 days of culture. Each fibroblast
was then expanded at a 1:3 ratio by trypsin-EDTA into
10 cm petri dishes. We used fibroblasts passaged for up
to 8 population doublings (PDs) for subsequent experi-
ments, in order to minimize clonal selection and culture
stress which could occur during extended tissue culture.Immunohistochemical staining (IHC)
Cells or tissues were fixed for 30 min with 4% formalin
and rinsed with phosphate buffered saline (PBS). After
endogenous peroxidase activity was quenched with 0.3%
H2O2, cells were blocked with normal nonimmune
serum for 30 min prior to being incubated with primary
antibody at 37°C for 2 hrs. Cells or tissues were then
labeled with streptavidin-biotin-horseradish peroxidase
staining kit (Dako, Carpinteria, CA, USA). The presence
of labeled peroxidase on the sections was visualized by
incubation with 3,30-diaminobenzidine, DAB + substrate
chromogen and the sections were counterstained with
hematoxylin. Negative control slides were performed by
omission of the primary antibody.
TAGLN expression was assessed by the intensity of
stained cells, and determined in two categories (weak
positive and strong positive). The staining intensity was
classified according to four grades (intensity scores): no
staining (grade 0), light brown staining (grade 1), brown
staining (grade 2), and dark brown staining (grade 3).
Grade 0 and grade 1 was defined as weak positive, grade
2 and grade 3 were defined as strong positive.
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Total RNA was extracted using Trizol reagent (Invitrogen,
Carlsbad, CA, USA) following the manufacturer’s instruc-
tions. cDNA was obtained with 1 μg RNA using Reverse
Transcription System Kit (Promega, Madison, WI, USA)
and QRT-PCR was performed by the SYBR Green PCR
core Reagent kit (Applied Biosystems, Warrington, UK).
Primers specific to TAGLN were as follows: 50-GAGCA
AGCTGGTGAACAGCC-30 (upper), 50-GACCATGGAG
GGTGGGT TCT-30 (lower). Glyceral-dehyde-3-phosphate
dehydrogenase (GAPDH) was used as the endogenous
reference. Its sequences were 50-GGACCTGACCTGCC
GTCT AG-30 (upper), 50-GTAGCCCAGGATGCCCTT
GA-30 (lower). QRT-PCR for quantitation of the mRNA
levels of TAGLN was done on an ABI Prism 7000
(Applied Biosystems, Foster City, CA, USA). Data were
analyzed by using the comparative Ct method. Specificity
of resulting PCR products was confirmed by melting
curves.Western blot
Cells were harvested and lysed with mammalian protein
extraction reagent (Pierce, Rockford, IL, USA). Protein
concentrations were determined with a bicinchoninic
acid (BCA) protein assay kit (Pierce, Rockford, IL, USA).
Samples containing 50 μg of total protein were loaded onto
each lane of 12% acrylamide gel in a minigel apparatus
(Bio-Rad, Richmond, CA, USA). The separated proteins
were transferred to a polyvinylidene difluoride (PVDF)
membrane (Bio-Rad, Richmond, CA, USA). After be-
ing incubated with primary antibody (1:1,000) and
HRP-conjugated secondary antibody (1:5,000) respectively,
immune complexes were detected by the enhanced
chemiluminescent (ECL) system (Millipore, Bedford, MA,
USA).Enzyme-linked immunosorbent assay (ELISA)
The protein levels of MMP-2 in supernatants were mea-
sured by an ELISA kit (R&D Systems Inc., Minneapolis,
MN, USA) according to the manufacturer’s instructions.Cell growth assay
The different groups of cells (1 × 103) were seeded into
96-well plates in triplicate. The number of viable cells
was determined daily using the Cell Counting Kit (CCK-8)
by utilizing a highly water-soluble tetrazolium salt WST-8
[2-(2-methoxy-4- nitrophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt]
(Dojindo, Japan). Briefly, 20 μl of CCK-8 solution was
added into plates, absorbance at 450 nm was measured
after 4 hrs incubation.Assessment of tumor invasion and migration
Tumor invasion and migration assay were performed with
QCMTM24-well invasion kit (Millipore, Bedford, MA,
USA) and QCMTM24-well migration kit (Millipore,
Bedford, MA, USA) according to the protocol provided
by the manufacturer, respectively. Add prepared MKN-45
cell suspension (2 × 105 cells/well) to the upper chamber
and add pre-suspended fibroblasts (5 × 104 cells/well in
RPMI 1640 medium containing 20% FBS) to the lower
chamber. The TAGLN of some fibroblasts in lower
chambers was inhibited using siRNA 24 hrs later. MKN-45
and fibroblasts were co-cultured non-contactedly for
48 hrs, then lysised the cells and determined RFU values
with a fluorescence plate reader using 480/520 nm filter set.
TAGLN siRNA
The Qiagen software was used to design RNAi
sequences targeting human TAGLN (Accession no.
NM_003186), and the siRNA sequence with the highest
putative efficacy (sense: 50-AAAUCGAGAAGAAGUA
UGAdtdt-30, antisense: 50-UCAUAC UUCUUCUCGAU
UUdtdt-30) was synthesized by Shanghai GeneChem Co,
Ltd. siRNA with randomized sequence (sense: 50-UUCU
CCGAACGUGUCACG Utt-30, antisense: 50-ACGUGAC
ACGUUCGGAGAAtt-30) against no gene (scrambled
siRNA group) was transfected as internal control. For
experiments, cells were transfected with the DOTAP lipo-
somal transfection reagent (Roche, Germany). Cells were
seeded at 2 × 105 cells/well in 6-well plates. After 24 hrs
when cells were in the phase of log growth, 250 μl
Opti-MEM I was mixed with 5 μl of 20 μM siRNA
duplex, while another 250 μl Opti-MEM I was separately
incubated with 11.88 μl of DOTAP liposome. The two
mixtures were gently mixed, and incubated for about
30 min at room temperature. For transfection, the entire
mixture was added to each well in 1.5 ml of fresh medium
without antibiotics. The final transfected concentration of
siRNA was 20 nM. Cells were collected for further assay
at 24, 48 and 72 hrs after transfection.
Gelatin zymography
The culture supernatants were harvested at 24 hrs and
mixed with a gel sample buffer (0.5 M Tris–HCl, glycerol,
10% sodium dodecyl sulfate [SDS], β-mercaptoethanol, and
0.5% bromophenol blue). Ten micrograms of protein were
taken by SDS-PAGE separation; the SDS-PAGE gels
contained 0.1% gelatin (Sigma Chemical, St Louis, MO,
USA). After electrophoresis, the gels were washed in
50 mM Tris buffer containing 2.5% Triton X-100. The gels
were incubated for an additional 24 hrs in incubation fluid
(50 mM Tris buffer [pH 7.6], 10 mM CaCl2, and 200 mM
NaCl). The gels were stained with 0.5% Coomassie blue,
white bands (72 kDa) on a blue background indicated zones
of digestion corresponding to the presence of MMP-2.
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Female BALB/c nu/nu nude mice, age-matched between
4–5 weeks (Institute of Zoology Chinese Academy of
Sciences), were housed at a specific pathogen-free environ-
ment in the Animal Laboratory Unit, Shanghai Jiao Tong
University School of Medicine, China. Fibroblasts and
MKN-45 were mixed at the ratio of 1:4 within 0.1 ml PBS
and injected into the lateral tail vein. Six mice were
included in each group in all experiments, and each
experiment was performed twice. Animals were sacrificed
and lung metastatic nodules were recorded 6 weeks after
tumor cell implantation. Tumor specimens were collected,
mixed in formalin, embedded in paraffin, and subjected
to H&E staining. Mice were manipulated and cared
according to the guidelines and protocols approved by
the Medical Experimental Animal Care Commission of
Shanghai Jiaotong University School of Medicine.
Statistical analysis
All experiments were repeated at least three times. Results
were summarized as means ± standard deviation (SD).
The correlation between TAGLN expression and clinico-
pathological parameters was calculated with two-sided
chi-square test. P < 0.05 was selected as the statistically
signignificant value. SPSS version 11.0 software was used
for all analyses.
Competing interests
The authors declare no competing interest in this paper.
Authors’ contributions
BQY and XHC conducted the experiments. BQY and BYL made the
hypothesis, designed the experiments and wrote the manuscript. JFL, YQ
and LPS provided assistance in some of the experiments. BQY and YBP
collect the specimens. JH, JY, YYY, QLG and ZGZ supervised the study. All
authors read and approved the final manuscript.
Acknowledgments
This work was supported by the grands from National Natural Science
Foundation of China (No. 30872476), National High Technology Research
and Development Program of China (863 Program, No. 2006AA02A301, No.
2007AA02Z179), Science and Technology Commission of Shanghai
Municipality (No. 09DZ1950100, No. 09DZ2260200), Shanghai Key Discipline
(S30204) and Key Projects in the National Science & Technology Pillar
Program (No. 2008BA152B03).
Author details
1Key Laboratory of Shanghai Gastric Neoplasms, Department of Surgery,
Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong
University School of Medicine, Shanghai 200025, China. 2Department of
Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of
Medicine, Shanghai 200025, China. 3National Human Genome Center at
Shanghai, Shanghai 201203, China. 4James Graham Brown Cancer Center,
University of Louisville, Louisville, KY 40202, USA.
Received: 21 November 2012 Accepted: 15 March 2013
Published: 19 March 2013
References
1. Eccles SA, Welch DR: Metastasis: recent discoveries and novel treatment
strategies. Lancet 2007, 369(9574):1742–1757.
2. Plummer M, Franceschi S, Munoz N: Epidemiology of gastric cancer.
IARC Sci Publ 2004, 157:311–326.3. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of
cancer cells in metastatic sites. Nature reviews 2002, 2(8):563–572.
4. Gout S, Huot J: Role of cancer microenvironment in metastasis: focus on
colon cancer. Cancer Microenviron 2008, 1(1):69–83.
5. Assinder SJ, Stanton JA, Prasad PD: Transgelin: an actin-binding protein
and tumour suppressor. Int J Biochem Cell Biol 2009, 41(3):482–486.
6. Thompson O, Moghraby JS, Ayscough KR, Winder SJ: Depletion of the
actin bundling protein SM22/transgelin increases actin dynamics and
enhances the tumourigenic phenotypes of cells. BMC cell biology 2012,
13:1.
7. Lee EK, Han GY, Park HW, Song YJ, Kim CW: Transgelin promotes
migration and invasion of cancer stem cells. Journal of proteome research
2010, 9(10):5108–5117.
8. Rho JH, Roehrl MH, Wang JY: Tissue proteomics reveals differential and
compartment-specific expression of the homologs transgelin and
transgelin-2 in lung adenocarcinoma and its stroma. Journal of proteome
research 2009, 8(12):5610–5618.
9. Korkaya H, Liu S, Wicha MS: Breast cancer stem cells, cytokine networks,
and the tumor microenvironment. J Clin Investig 2011, 121(10):3804–3809.
10. Lorusso G, Ruegg C: The tumor microenvironment and its contribution to
tumor evolution toward metastasis. Histochemistry and cell biology 2008,
130(6):1091–1103.
11. Bhowmick NA, Moses HL: Tumor-stroma interactions. Curr Opin Genet Dev
2005, 15(1):97–101.
12. Kitadai Y: Cancer-stromal cell interaction and tumor angiogenesis in
gastric cancer. Cancer Microenviron 2010, 3(1):109–116.
13. Mueller MM, Fusenig NE: Tumor-stroma interactions directing phenotype
and progression of epithelial skin tumor cells. Differentiation; research in
biological diversity 2002, 70(9–10):486–497.
14. Mitra S, Stemke-Hale K, Mills GB, Claerhout S: Interactions between tumor
cells and microenvironment in breast cancer: a new opportunity for
targeted therapy. Cancer science 2012, 103(3):400–407.
15. Kalluri R, Zeisberg M: Fibroblasts in cancer. Nature reviews 2006,
6(5):392–401.
16. Bhowmick NA, Neilson EG, Moses HL: Stromal fibroblasts in cancer
initiation and progression. Nature 2004, 432(7015):332–337.
17. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R,
Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in
invasive human breast carcinomas promote tumor growth and
angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005,
121(3):335–348.
18. Witz IP: Tumor-microenvironment interactions: dangerous liaisons.
Adv Cancer Res 2008, 100:203–229.
19. Kiaris H, Chatzistamou I, Kalofoutis C, Koutselini H, Piperi C, Kalofoutis A:
Tumour-stroma interactions in carcinogenesis: basic aspects and
perspectives. Mol Cell Biochem 2004, 261(1–2):117–122.
20. Scherer RL, McIntyre JO, Matrisian LM: Imaging matrix metalloproteinases
in cancer. Cancer Metastasis Rev 2008, 27(4):679–690.
21. Kessenbrock K, Plaks V, Werb Z: Matrix metalloproteinases: regulators of
the tumor microenvironment. Cell 2010, 141(1):52–67.
22. Cunha GR, Hayward SW, Wang YZ, Ricke WA: Role of the stromal
microenvironment in carcinogenesis of the prostate. Int J Cancer 2003,
107(1):1–10.
23. Semba S, Kodama Y, Ohnuma K, Mizuuchi E, Masuda R, Yashiro M, Hirakawa
K, Yokozaki H: Direct cancer-stromal interaction increases fibroblast
proliferation and enhances invasive properties of scirrhous-type gastric
carcinoma cells. Br J Cancer 2009, 101(8):1365–1373.
24. Li L, Miano JM, Cserjesi P, Olson EN: SM22 alpha, a marker of adult
smooth muscle, is expressed in multiple myogenic lineages during
embryogenesis. Circ Res 1996, 78(2):188–195.
25. Lawson D, Harrison M, Shapland C: Fibroblast transgelin and smooth
muscle SM22alpha are the same protein, the expression of which is
down-regulated in many cell lines. Cell motility and the cytoskeleton 1997,
38(3):250–257.
26. Mukaratirwa S, Koninkx JF, Gruys E, Nederbragt H: Mutual paracrine effects
of colorectal tumour cells and stromal cells: modulation of tumour and
stromal cell differentiation and extracellular matrix component
production in culture. Int J Exp Pathol 2005, 86(4):219–229.
27. Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, Lee GS, Yom HC: The
proteomics approach to find biomarkers in gastric cancer. Journal of
Korean medical science 2003, 18(4):505–509.
Yu et al. BMC Cell Biology 2013, 14:17 Page 10 of 10
http://www.biomedcentral.com/1471-2121/14/1728. Klade CS, Voss T, Krystek E, Ahorn H, Zatloukal K, Pummer K, Adolf GR:
Identification of tumor antigens in renal cell carcinoma by serological
proteome analysis. Proteomics 2001, 1(7):890–898.
29. Zipin A, Israeli-Amit M, Meshel T, Sagi-Assif O, Yron I, Lifshitz V, Bacharach E,
Smorodinsky NI, Many A, Czernilofsky PA, et al: Tumor-microenvironment
interactions: the fucose-generating FX enzyme controls adhesive
properties of colorectal cancer cells. Cancer Res 2004, 64(18):6571–6578.
30. Daniel C, Ludke A, Wagner A, Todorov VT, Hohenstein B, Hugo C:
Transgelin is a marker of repopulating mesangial cells after injury and
promotes their proliferation and migration. Laboratory investigation; a
journal of technical methods and pathology 2012, 92(6):812–826.
31. Dos Santos Hidalgo G, Meola J, Rosa ESJC, Paro de Paz CC, Ferriani RA:
TAGLN expression is deregulated in endometriosis and may be involved
in cell invasion, migration, and differentiation. Fertil Steril 2011,
96(3):700–703.
32. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C: Stimulation of matrix
metalloproteinase production by recombinant extracellular matrix
metalloproteinase inducer from transfected Chinese hamster ovary cells.
J Biol Chem 1997, 272(1):24–27.
33. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y: Co-culture of human
breast adenocarcinoma MCF-7 cells and human dermal fibroblasts
enhances the production of matrix metalloproteinases 1, 2 and 3 in
fibroblasts. Br J Cancer 1995, 71(5):1039–1045.
34. Klein G, Vellenga E, Fraaije MW, Kamps WA, de Bont ES: The possible role
of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute
leukemia. Critical reviews in oncology/hematology 2004, 50(2):87–100.
35. Luo J: Role of matrix metalloproteinase-2 in ethanol-induced invasion by
breast cancer cells. J Gastroenterol Hepatol 2006, 21(Suppl 3):S65–S68.
doi:10.1186/1471-2121-14-17
Cite this article as: Yu et al.: Stromal fibroblasts in the
microenvironment of gastric carcinomas promote tumor metastasis via
upregulating TAGLN expression. BMC Cell Biology 2013 14:17.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
